PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
18829893-2	2009	We demonstrated previously that 4-phenylbutyrate (4PBA) treatment, a U.S. Food and Drug Administration-approved drug for the treatment of urea cycle disorders, induces the cell-surface expression of BSEP by prolonging the degradation rate of cell-surface-resident BSEP.	4-phenylbutyric acid	32-48	ATP binding cassette subfamily B member 11	Rattus norvegicus	199-203	
18829893-2	2009	We demonstrated previously that 4-phenylbutyrate (4PBA) treatment, a U.S. Food and Drug Administration-approved drug for the treatment of urea cycle disorders, induces the cell-surface expression of BSEP by prolonging the degradation rate of cell-surface-resident BSEP.	4-phenylbutyric acid	32-48	ATP binding cassette subfamily B member 11	Rattus norvegicus	264-268